Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Moodys
Baxter
Cerilliant
Daiichi Sankyo
Medtronic
Colorcon
Covington
Dow

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076447

« Back to Dashboard

NDA 076447 describes FEXOFENADINE HYDROCHLORIDE HIVES, which is a drug marketed by Dr Reddys Labs Ltd, Mylan, Sciegen Pharms Inc, Sun Pharm Inds, Teva, and Wockhardt Ltd, and is included in six NDAs. It is available from ninety-two suppliers. Additional details are available on the FEXOFENADINE HYDROCHLORIDE HIVES profile page.

The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and nine suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
Summary for 076447
Tradename:FEXOFENADINE HYDROCHLORIDE HIVES
Applicant:Teva
Ingredient:fexofenadine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076447
Suppliers and Packaging for NDA: 076447
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076447 ANDA L. Perrigo Company 0113-0425 0113-0425-53 2 BLISTER PACK in 1 CARTON (0113-0425-53) > 6 TABLET, FILM COATED in 1 BLISTER PACK
CHILDREN'S FEXOFENADINE HYDROCHLORIDE ALLERGY fexofenadine hydrochloride TABLET;ORAL 076447 ANDA L. Perrigo Company 0113-0571 0113-0571-22 15 BLISTER PACK in 1 CARTON (0113-0571-22) > 1 TABLET, FILM COATED in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength30MG
Approval Date:Sep 1, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Sep 1, 2005TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength180MG
Approval Date:Sep 1, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Citi
Chubb
Cerilliant
Cipla
Daiichi Sankyo
McKinsey
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.